Suppr超能文献

细菌核糖体蛋白L3中的突变及其与抗生素耐药性的关联。

Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.

作者信息

Klitgaard Rasmus N, Ntokou Eleni, Nørgaard Katrine, Biltoft Daniel, Hansen Lykke H, Trædholm Nicolai M, Kongsted Jacob, Vester Birte

机构信息

Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark.

Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense M, Denmark.

出版信息

Antimicrob Agents Chemother. 2015;59(6):3518-28. doi: 10.1128/AAC.00179-15. Epub 2015 Apr 6.

Abstract

Different groups of antibiotics bind to the peptidyl transferase center (PTC) in the large subunit of the bacterial ribosome. Resistance to these groups of antibiotics has often been linked with mutations or methylations of the 23S rRNA. In recent years, there has been a rise in the number of studies where mutations have been found in the ribosomal protein L3 in bacterial strains resistant to PTC-targeting antibiotics but there is often no evidence that these mutations actually confer antibiotic resistance. In this study, a plasmid exchange system was used to replace plasmid-carried wild-type genes with mutated L3 genes in a chromosomal L3 deletion strain. In this way, the essential L3 gene is available for the bacteria while allowing replacement of the wild type with mutated L3 genes. This enables investigation of the effect of single mutations in Escherichia coli without a wild-type L3 background. Ten plasmid-carried mutated L3 genes were constructed, and their effect on growth and antibiotic susceptibility was investigated. Additionally, computational modeling of the impact of L3 mutations in E. coli was used to assess changes in 50S structure and antibiotic binding. All mutations are placed in the loops of L3 near the PTC. Growth data show that 9 of the 10 mutations were well accepted in E. coli, although some of them came with a fitness cost. Only one of the mutants exhibited reduced susceptibility to linezolid, while five exhibited reduced susceptibility to tiamulin.

摘要

不同类别的抗生素会结合到细菌核糖体大亚基中的肽基转移酶中心(PTC)。对这些类抗生素的耐药性常常与23S rRNA的突变或甲基化有关。近年来,在对靶向PTC的抗生素耐药的细菌菌株中,核糖体蛋白L3发生突变的研究数量有所增加,但往往没有证据表明这些突变实际上赋予了抗生素耐药性。在本研究中,使用了一种质粒交换系统,在染色体L3缺失菌株中用突变的L3基因替换质粒携带的野生型基因。通过这种方式,对于细菌来说,必需的L3基因是可用的,同时允许用突变的L3基因替换野生型。这使得在没有野生型L3背景的情况下,能够研究大肠杆菌中单个突变的影响。构建了10个质粒携带的突变L3基因,并研究了它们对生长和抗生素敏感性的影响。此外,利用大肠杆菌中L3突变影响的计算模型来评估50S结构和抗生素结合的变化。所有突变都位于靠近PTC的L3环中。生长数据表明,10个突变中有9个在大肠杆菌中能被很好地接受,尽管其中一些伴随着适应性代价。只有一个突变体对利奈唑胺的敏感性降低,而有五个对泰妙菌素的敏感性降低。

相似文献

1
Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.
Antimicrob Agents Chemother. 2015;59(6):3518-28. doi: 10.1128/AAC.00179-15. Epub 2015 Apr 6.
2
Combined Effect of the Cfr Methyltransferase and Ribosomal Protein L3 Mutations on Resistance to Ribosome-Targeting Antibiotics.
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00862-17. Print 2017 Sep.
6
Resistance to the peptidyl transferase inhibitor tiamulin caused by mutation of ribosomal protein l3.
Antimicrob Agents Chemother. 2003 Sep;47(9):2892-6. doi: 10.1128/AAC.47.9.2892-2896.2003.
10
The contribution of common rpsL mutations in Escherichia coli to sensitivity to ribosome targeting antibiotics.
Int J Med Microbiol. 2013 Dec;303(8):558-62. doi: 10.1016/j.ijmm.2013.07.006. Epub 2013 Jul 31.

引用本文的文献

1
Analysis of stress response in multiple bacterial pathogens using a network biology approach.
Sci Rep. 2025 May 2;15(1):15342. doi: 10.1038/s41598-025-91269-5.
2
Diversity in Adaptive Evolution of Methicillin-Resistant Clinical Isolates Under Exposure to Continuous Linezolid Stress in vitro.
Infect Drug Resist. 2025 Feb 11;18:819-834. doi: 10.2147/IDR.S493139. eCollection 2025.
3
A cell-free strategy for host-specific profiling of intracellular antibiotic sensitivity and resistance.
NPJ Antimicrob Resist. 2023 Dec 18;1(1):16. doi: 10.1038/s44259-023-00018-z.
4
Ribosomal proteins in hepatocellular carcinoma: mysterious but promising.
Cell Biosci. 2024 Nov 1;14(1):133. doi: 10.1186/s13578-024-01316-3.
6
Mechanisms of Linezolid Resistance in Mycobacteria.
Pharmaceuticals (Basel). 2023 May 24;16(6):784. doi: 10.3390/ph16060784.
8
Characterization of Linezolid-Analogue L3-Resistance Mutation in .
Microorganisms. 2023 Mar 8;11(3):700. doi: 10.3390/microorganisms11030700.
10
Ψ-Footprinting approach for the identification of protein synthesis inhibitor producers.
NAR Genom Bioinform. 2022 Jul 15;4(3):lqac055. doi: 10.1093/nargab/lqac055. eCollection 2022 Sep.

本文引用的文献

2
Linezolid-Resistant Staphylococcus epidermidis, Portugal, 2012.
Emerg Infect Dis. 2014 May;20(5):903-5. doi: 10.3201/eid2005.130783.
3
A new system for naming ribosomal proteins.
Curr Opin Struct Biol. 2014 Feb;24:165-9. doi: 10.1016/j.sbi.2014.01.002. Epub 2014 Feb 10.
4
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12).
J Antimicrob Chemother. 2014 Jun;69(6):1582-8. doi: 10.1093/jac/dkt541. Epub 2014 Jan 26.
6
8
Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations.
Antimicrob Agents Chemother. 2013 Aug;57(8):4082-3. doi: 10.1128/AAC.00437-13. Epub 2013 May 20.
9
10
Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy.
J Clin Microbiol. 2013 Apr;51(4):1256-9. doi: 10.1128/JCM.00098-13. Epub 2013 Jan 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验